News for hackers. Stuff that matters.
Re:Trial results for new lung cancer drug are 'off the charts' by ilya_m on Friday May 31, 2024 @07:45PM (#40541423)
>>>>Even after 60.2 months of follow-up, the median progression-free survival has not yet been reached [1]

> This sounds awful? Or contradictory at best?

No, quite amazing. At 5 years more than 50% of participants are progression-free. That's indeed off the charts for a metastatic lung cancer.

There are no comments on this comment yet.